Where each model wins on economics
Portal-gated pricing can win when a clinic values one login across 503A, 503B, and brand medications, when flat $30 cold-chain shipping per patient order simplifies ops planning, and when network-scale buying delivers competitive rates at the buyer's volume. The risk is that the rate is unverifiable up front and may pair with platform fees that change total cost of ownership. Pass-through pricing wins when a clinic needs to quote cash-pay patients on landed cost before the consult, wants to verify that drug cost is not marked up, batches patient-specific 503A refills in one cart, and values seeing the number on every SKU before ordering.
Most cash-pay clinics care most about one thing: knowing per-vial cost before they set patient pricing. That single requirement tends to favor a pass-through model, because portal rates that arrive after signup cannot inform pricing you need to set during evaluation. But a clinic that relies on 503B office-use SKUs or needs EMR integrations from a procurement hub may rationally prefer BoomRx — the right answer depends on the clinic, not the marketing.